腹主动脉瘤患者调节性T细胞体外扩增抑制人源化小鼠模型动脉瘤形成
本研究探讨腹主动脉瘤(AAA)患者调节性T细胞(Tregs)体外扩增后能否抑制人源化小鼠模型中的动脉瘤形成。方法包括检测AAA患者循环Treg比例,并将人CD4+ T细胞移植至Rag1-/-小鼠后诱导动脉瘤。结果显示AAA患者Treg比例降低,人CD4+ T细胞可驱动动脉瘤形成,而经白介素-2体外扩增的Tregs可减少动脉瘤进展。结论提示体外扩增人Tregs可能是抑制AAA进展的潜在治疗策略。
要点
- AAA患者循环Treg比例较匹配对照降低。
- 人CD4+ T细胞可在Rag1-/-小鼠中驱动动脉瘤形成。
- 白介素-2体外扩增人Tregs可减少动脉瘤进展。
核心结论
- 体外扩增人Tregs可能成为抑制AAA进展的潜在治疗策略。
研究设计与样本
- 研究比较AAA患者与年龄性别匹配对照的循环Treg群体,采用实时PCR和流式细胞术检测。
- 构建人源化小鼠模型:7周龄Rag1-/-小鼠接受5×10^6人CD4+ T细胞腹腔注射后行CaCl2诱导动脉瘤。
- 在动脉瘤诱导前及诱导后6周测量主动脉直径,并收集主动脉组织进行组织学和蛋白提取。
主要发现
- AAA患者外周血单核细胞中Treg比例较匹配的显著血管疾病对照患者降低。
- 人CD4+ T细胞能够驱动Rag1-/-小鼠动脉瘤形成。
- 经白介素-2体外扩增人Tregs后,动脉瘤进展减少。
临床怎么用
- 研究提示扩增Tregs可能作为抑制AAA进展的免疫调节策略,但尚未进入临床实践。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Abdominal aortic aneurysm (AAA) is a chronic inflammatory disease. Studies of human aneurysm tissue demonstrate dense inflammatory cell infiltrates with CD4+ T cells predominating. Regulatory T cells (Tregs) play an important role in inhibiting pro-inflammatory T cell proliferation, therefore, limiting collateral tissue destruction. The aim of this study was to investigate whether ex vivo augmentation of human Tregs attenuates aneurysm formation in humanized murine model of AAA. METHODS: Circulating Treg population in AAA patients and age- and gender-matched controls were determined by real-time polymerase chain reaction and flow cytometry. To create humanized murine model of AAA, irradiated Rag1-deficient (Rag1-/-) mice, without mature T lymphocytes, at 7 weeks of age were given 5 × 106 of human CD4+ T cells intraperitoneally. Then the mice underwent CaCl2 aneurysm induction. Aortic diameters were measured before and at 6 weeks after aneurysm induction. Aortic tissue was collected for histology and protein extraction. Verhoeff-Van Gieson stain was used for staining elastic fiber. CD4+ T cells in the aortic tissue were detected by immunohistochemical staining. RESULTS: In human peripheral blood mononuclear cells, the proportion of Tregs are decreased in AAA patients compared with matched control patients with significant vascular disease. We first validated the role of Tregs in the CaCl2 model of AAA. To determine the role of human T cells in AAA formation, Rag1-/- mice, resistant to CaCl2-aneurysm induction, were transplanted with human CD4+ T cells. Human CD4+ T cells were able to drive aneurysm formation in Rag1-/- mice. We show that ex vivo augmentation of human Tregs by interleukin-2 resulted in decreased aneurysm progression. CONCLUSIONS: These data suggest that the ex vivo expansion of human Tregs may be a potential therapeutic strategy for inhibiting progression of AAA.
引用
- Suh MK, Batra R, Carson JS, et al. Ex vivo expansion of regulatory T cells from abdominal aortic aneurysm patients inhibits aneurysm in humanized murine model. J Vasc Surg. 2020. PMID: 31980239. doi:10.1016/j.jvs.2019.08.285
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。